In anti-citrullinated protein antibody positive rheumatoid arthritis (ACPA-positive RA), a 25 particular subset of HLA-DRB1 alleles, called shared epitope alleles (SE) 
Introduction
EIRA was considered as a discovery cohort to test for enrichment of significant interactions 119 between the HLA-DRB1 SE alleles and the set of SNPs enriched for risk SNPs from this study. 120
The risk SNPs represent 5% of the variants analyzed for interaction in EIRA. Out of these risk 121
SNPs, 24.5% of them exhibited an AP p-value (attributable proportion due to interaction p-122 value) less than 0.05 (Table 2 (Figure 2 ). KS test p-value <2.2e-16 for both EIRA and NARAC. As it is mentioned in 138 the materials and methods, these KS test p-values are lower than the machine precision, meaning that when the precise p-value was calculated 139 the result was 0.
141
The difference in the distribution of the whole spectrum of AP p-values does not directly inform 142 about the performance of the values below significance threshold of 0.05. Therefore, we 143 specifically tested for difference in this segment of the AP p-values distributions for risk and 144 non-risk SNPs. We found a strong enrichment of significant interactions in the group of risk 145 variants in comparison with the non-risk variants (KS test D=0.25, p-values <2.2e-16, Fig. 2d  146 to Fig. 2f ). This suggests that the significant difference between the ECDF from the risk and 147 non-risk groups detected in the full distribution of AP p-values is principally due to the 148 enrichment of small AP p-values in the risk group of SNPs. 149
Since genetic variants located in the PTPN22 gene are the second most important genetic risk 150 factor for RA in Caucasians (Fig. 1a) , we excluded the SNPs of this locus from the analysis and 151 DRB1 SE alleles is due to multiple variants, and it is not explained by the PTPN22 locus alone. 156
157
The ECDF difference between the AP p-values from the risk and non-risk variants almost 158 disappeared completely when the rs4507692 SNP was tested instead of the HLA-DRB1 SE 159 variable as a negative control (Table 1, Supplementary Material Table S1 ). We found that the 160 proportion of interacting risk SNPs with rs4507692 variant dropped to 2.8%, (Supplementary 161 Material Table S1 and Consistent results were observed when the workflow was applied to only non-imputed 170 genotyping data for EIRA (Supplementary Material Fig. 2j to Fig. 2l ). As in EIRA, when the rs4507694 SNP was 196 used in the workflow instead of the HLA-DRB1 SE alleles, there was not an enrichment of 197 significant interactions in the risk group (2.6%) compared to the non-risk group (3%) of SNPs 198 (Supplementary Material Table S1 , Table S2 ). 204
205
Step-by-step discount of the risk alleles of top interacting SNPs decreases the HLA-DRB1 SE 206
The definition of additive interaction model predicts that removing individuals with an 208
interacting allele from the analysis should decrease the effect size of the HLA-DRB1 SE alleles 209 among the remaining subjects. To directly determine if the OR for the HLA-DRB1 SE alleles in 210 ACPA-positive RA is affected by the absence or presence of other risk alleles from SNPs in 211 interaction with the HLA-DRB1 SE alleles, we calculated the combined OR for the HLA-DRB1 212 SE alleles, including and excluding the effect of two of the top SNPs in interaction. Figure 3  213 shows how the combined OR is affected by the exclusion of individuals with one or both of the 214 risk alleles of the selected SNPs in combination with the HLA-DRB1 SE alleles. Importantly, 215 in EIRA, removing the risk alleles gradually decreases the ORs from 11.48 (8.9-14.9 95%CI; 216 YGG: SE positive, rs2077507G, rs1004664G) to 3.97 after removing one risk allele (95%CI: 217 3.3 -4.7; YAG: SE positive, rs2077507A, rs1004664G) or to 4.11 after removing the other risk 218 allele (95%CI: 3.3 -5.1; YGT: SE positive, rs2077507G, rs1004664T) and finally, to an OR of 219 2.57 when both risk alleles are removed (95%CI: 2.2 -2.9; YAT: SE positive, rs2077507A, 220 rs1004664T, Fig. 3a) . A similar result was seen in the NARAC study for the top interacting 221 SNPs (Fig. 3b) . This gradual drop in effect size indicates that the high OR of the HLA-DRB1 222 SE alleles in the disease could be at least partially attributed to the interaction with other SNPs, 223 which exhibit modest individual effect on the risk for ACPA-positive RA. 224
225
An exploration of selected SNPs in interaction with the HLA-DRB1 SE alleles from EIRA and 226
NARAC. 227
We identified 1,492 SNPs in interaction with the HLA-DRB1 SE alleles with AP p-values <0.05 228 and the same direction of AP when comparing the results from the EIRA and NARAC studies 229 (Supplementary Material Table S3 ). 230
Figures 4a and 4b visualize how these 1,492 SNPs are distributed across the genome. We ranked 231 the chromosomes based on the minimum AP p-value, the maximum AP value, and the 232 percentage of these 1,492 SNPs in interaction with the HLA-DRB1 SE alleles (Supplementary  233   Material Table S4 ). Based on these criteria, chromosomes 1 and 9 reach the highest position 234 for both studied cohorts (minimum AP p-value 4.3e-10 in EIRA and 1.6e-08 in NARAC; 235 Supplementary Material Table S4 ). Chromosomes 2, 7, 8, and 13 followed in the ranking when 236 the results from both EIRA and NARAC were considered. The majority (84.6%) of these SNPs 237 in interaction with the HLA-DRB1 SE alleles exhibited a positive AP, and most of them had 238 values under 0.5 ( Fig. 4a and Fig. 4b Material Fig S3) . Since these SE-eQTLs are 248 context related, it gives biological evidence for the statistically detected interactions between 249 these variants and the HLA-DRB1 SE alleles. 250
The loci 9q33 ( Fig. 4c and Fig. 4d ) and 1p13 ( Fig. 4g and Fig. 4h) Table S5 ). On the other hand, the top SNP in interaction with the 261 HLA-DRB1 SE alleles is the non-synonymous variant rs2476601 in the PTPN22 gene located 262 in the 1p13 locus ( Fig. 4g and Fig. 4h ). Although the interaction between rs2476601 SNP and 263 the HLA-DRB1 SE alleles in ACPA-positive RA has been reported previously (7), we observed 264 in our SE-eQTLs analysis that the rs2476601 SNP is an SE-eQTL for HIPK1 (homeodomain 265 interacting protein kinase 1), PTPN22 (protein tyrosine phosphatase, non-receptor type 22), and 266 CSDE1 (cold shock domain containing E1) genes (Fig. 4i to Fig. 4k Table S3 ). Thus, these results require additional replication in 285 independent cohorts of ACPA-positive RA patients and controls. 286
Finally, we observed that the step-by-step removal of the risk alleles of the two-top replicated 287
SNPs in interaction with the HLA-DRB1 SE alleles (rs2476601 at 1p13 and rs10739581 at 9q33, 288 AP FDR q-value<0.05), decreases the effect size of SE alleles for ACPA positive RA in the 289 studied cohorts (Fig 5) . This observation also suggests that the association between the HLA-290 (Table 1) . 402
403

HLA genotyping 404
HLA typing in the EIRA study was made by sequence-specific primer polymerase chain 405 reaction assay (SSP-PCR) (DR low-resolution kit; Olerup SSP, Saltsjöbaden, Sweden), and the 406 PCR products were loaded into 2% agarose gels for electrophoresis. An interpretation table was 407 used to determine the specific genotype according to the manufacturer's instructions (33). In 408 the NARAC study, the HLA typing was also performed by SSP-PCR based methods as 409 described elsewhere (34). 410
HLA-DRB1 SE alleles included *01 (except *0103), *04 (using high resolution data for *0404, 411 
Interaction Analysis 444
After applying the filters mentioned above, we tested for additive interaction between the HLA-445 DRB1 SE and each SNP from the EIRA and NARAC GWAS. The null hypothesis of the 446 additive model assumes that there is additivity between the different sufficient causes for a 447 phenotype, while the alternative hypothesis is assumed when departure from additivity is 448 observed. The departure from additivity is estimated by the attributable proportion (AP) due to 449 interaction using OR as the risk estimates(40) with the following equation: 450
Where 1 and 0 refer to presence or absence of the risk factor/allele respectively, the ORs are 452 calculated using SE0SNP0 as a reference group. A cut-off of five for each of the cell frequencies 453 was applied in the interaction analysis. The gender and the first ten principal components from 454 PCA were included as covariates in the model. AP value, its respective p-value and confidence 455 interval (95%CI) were assessed using logistic regression by means of the program 456 GEISA(v0.1.12) (https://github.com/menzzana/geisa)(11, 41). An update JAVA coded 457 software of the previously published GEIRA algorithm (42). The numbers and the percentage 458 of SNPs analyzed for each studied cohort are presented in Table 2 . We evaluated whether the selected SNPs in interaction with the HLA-DRB1 SE alleles were 513 eQTLs in the HLA-DRB1 SE alleles context for genes 1Mbp around them (GRCh37/hg19 514 assembly was used) using data from the PBMCs found in the COMBINE study (44). Briefly, 515 the PBMCs from the RA patients were sampled at the Rheumatology Unit, Karolinska Institute, 516
Stockholm-Sweden. RNA was purified from the PBMC samples and sequenced using Illumina 517
HiSeq 2000 with TruSeq RNA sample preparation. DNA was genotyped using Illumina 518
OmniExpress arrays (12v1) (44). 519
The eQTLs in the context of the HLA-DRB1 SE alleles (SE-eQTLs) were analyzed in 97 ACPA-520 positive RA patients (69% females) that were undergoing a change or start of a new treatment 521 regimen. In the analysis, the following formula was applied: 522 Tables S6 and S7 
